Evidence map›Paper›PMID 41473483›Full record

ArticleIDCases2025

The global status of toxoplasmic myocarditis: A case series and systematic literature review.

Mostafa Tork, Mitra Sadeghi, Bahareh Basirpour, Alireza Fattahian, Somayyeh Ahmadi, Shahabeddin Sarvi, Lotfollah Davoodi, Maryam Hataminejad, Shirzad Gholami, Ahmad Daryani and 2 more

Abstract read
In one paragraph

Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mostafa TorkToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Mitra SadeghiToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Bahareh BasirpourToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Alireza FattahianDepartment of Cardiology, Cardiovascular Research Center of Mazandaran University of Medical Science, Sari, Iran.
Somayyeh AhmadiToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Shahabeddin SarviToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Lotfollah DavoodiAntimicrobial Resistance Research Center, Department of Infectious Diseases, Mazandaran University, Sari, Iran.
Maryam HataminejadToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Shirzad GholamiToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Ahmad DaryaniToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Sargis A AghayanLaboratory of Molecular Parasitology, Scientific Center of Zooloy and Hydroecology, NASRA, 7P. Sevak st., Yerevan 0014, Armenia.
Seyed Abdollah HosseiniToxoplasmosis Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Toxoplasmosis, an infection caused by the parasite Methods: In this systematic review, the searches were conducted across on main databases and followed the PRISMA guidelines to compile relevant studies. After eliminating duplicate entries and carefully assessing inclusion and exclusion criteria, we included 21 studies in our review. Subsequently, we analyzed the collected data. Results: Twenty one articles were analyzed, covering a total of 24 cases of toxoplasmic myocarditis. Among the patients, 75 % (18 cases) were male, while 25 % (6 cases) were female. The average age of those examined was 37.3 years. The findings indicated that serology and MRI tests play a crucial role in the definitive diagnosis of toxoplasmic myocarditis. However, in cases of deceased patients, confirmation was obtained through autopsy and tissue staining. Conclusion: The findings from this research highlight the significance of toxoplasmosis as a potential contributor to development of myocarditis, a condition to which cardiologists should pay attention. Diligent healthcare professionals, equipped with continuous monitoring and access to suitable therapeutic interventions, play a crucial role in assisting patients with myocarditis. By including toxoplasmosis as a myocarditis risk factors, cardiologists can ensure timely diagnosis, and providing appropriate treatment, which can impact on patient outcomes.

Indexed as

MyocarditisSystematic reviewToxoplasma gondii

Identifiers

PMID41473483
PMCPMC12747236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.